Showing results (1-10 of 6) with videos related to
Sort By:
Pageof 1
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|January 27, 2018
Molecular Imaging in Cancer Drug DevelopmentStijn J H Waaijer, Iris C Kok, Bertha Eisses, et al.Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|September 5, 2024
Whole-Body HER2 Heterogeneity Identified on HER2 PET in HER2-Negative, -Low, and -Positive Metastatic Breast CancerBertha Eisses, Jasper J L van Geel, Adrienne H Brouwers, et al.Diagnostics (Basel, Switzerland)|May 4, 2026
Circulating Tumor Cells Enhance Prognostic Stratification Beyond ER Assessment by Biopsy or FES-PET in Endocrine-Treated Metastatic Breast CancerBertha Eisses, Lindsay Angus, Evelien J M Kuip, et al.JAMA Oncology|April 16, 2026
18F-Fluorodeoxyglucose Positron Emission Tomography for Estimating Outcomes After Initial Treatment for Metastatic Breast Cancer: A Nonrandomized Clinical Cohort TrialJasper J L van Geel, Bertha Eisses, Sjoerd G Elias, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 17, 2022
[89Zr]Zr-DFO-girentuximab and [18F]FDG PET/CT to Predict Watchful Waiting Duration in Patients with Metastatic Clear-cell Renal Cell CarcinomaSarah R Verhoeff, Sjoukje F Oosting, Sjoerd G Elias, et al.Diagnostics (Basel, Switzerland)|February 24, 2024
Correlation between Histopathological Prognostic Tumor Characteristics and [<sup>18</sup>F]FDG Uptake in Corresponding Metastases in Newly Diagnosed Metastatic Breast CancerJorianne Boers, Bertha Eisses, Mieke C Zwager, et al.Pageof 1